- Home
- Publications
- Publication Search
- Publication Details
Title
Germline determinants of clinical outcome of cutaneous melanoma
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 29, Issue 1, Pages 15-26
Publisher
Wiley
Online
2015-09-05
DOI
10.1111/pcmr.12418
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidermal growth factor receptor tyrosine kinase inhibitors in early-stage nonsmall cell lung cancer
- (2015) Johanna N. Spaans et al. CURRENT OPINION IN ONCOLOGY
- Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma
- (2015) Justin Rendleman et al. JOURNAL OF MEDICAL GENETICS
- Association BetweenNRASandBRAFMutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
- (2015) Nancy E. Thomas et al. JAMA Oncology
- Pemetrexed-Carboplatin Adjuvant Chemotherapy With or Without Gefitinib in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Harbouring EGFR Mutations: A Randomized, Phase II Study
- (2014) Ning Li et al. ANNALS OF SURGICAL ONCOLOGY
- Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma
- (2014) M S Carlino et al. BRITISH JOURNAL OF CANCER
- Correlation of Somatic Mutations and Clinical Outcome in Melanoma Patients Treated with Carboplatin, Paclitaxel, and Sorafenib
- (2014) M. A. Wilson et al. CLINICAL CANCER RESEARCH
- Metalloproteinases in melanoma
- (2014) Nives Moro et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Inherited variation in the PARP1 gene and survival from melanoma
- (2014) John R. Davies et al. INTERNATIONAL JOURNAL OF CANCER
- PARP1polymorphisms play opposing roles in melanoma occurrence and survival
- (2014) Matthew H. Law et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients
- (2014) Swetlana Mactier et al. Pigment Cell & Melanoma Research
- Tissue prognostic biomarkers in primary cutaneous melanoma
- (2014) Mario Mandalà et al. VIRCHOWS ARCHIV
- CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2
- (2013) D Bedognetti et al. BRITISH JOURNAL OF CANCER
- Clinical characteristics and outcomes with specificBRAFandNRASmutations in patients with metastatic melanoma
- (2013) Amanda D. Bucheit et al. CANCER
- Gene Variants in Angiogenesis and Lymphangiogenesis and Cutaneous Melanoma Progression
- (2013) J. Y. Park et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study
- (2013) P. Queirolo et al. CANCER INVESTIGATION
- Melanoma risk loci as determinants of melanoma recurrence and survival
- (2013) Justin Rendleman et al. Journal of Translational Medicine
- Cutaneous melanoma
- (2013) Alexander MM Eggermont et al. LANCET
- Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients
- (2012) Andrés Tittarelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Association Between Colorectal Cancer Susceptibility Loci and Survival Time After Diagnosis With Colorectal Cancer
- (2012) Amanda I. Phipps et al. GASTROENTEROLOGY
- The role of genetic breast cancer susceptibility variants as prognostic factors
- (2012) Peter A. Fasching, Paul D.P. Pharoah, Angela Cox, Heli Nevanlinna, Stig E. Bojesen, Thomas Karn, Annegien Broeks, Flora E. van Leeuwen, Laura J. van 't Veer, Renate Udo, Alison M. Dunning, Dario Greco, Kristiina Aittomäki, Carl Blomqvist, Mitul Shah, Børge G. Nordestgaard, Henrik Flyger, John L. Hopper, Melissa C. Southey, Carmel Apicella, Montserrat Garcia-Closas, Mark Sherman, Jolanta Lissowska, Caroline Seynaeve, Petra E.A. Huijts, Rob A.E.M. Tollenaar, Argyrios Ziogas, Arif B. Ekici, Claudia Rauh, Arto Mannermaa, Vesa Kataja, Veli-Matti Kosma, Jaana M. Hartikainen, Irene L. Andrulis, Hilmi Ozcelik, Anna-Marie Mulligan, Gord Glendon, Per Hall, Kamila Czene, Jianjun Liu, Jenny Chang-Claude, Shan Wang-Gohrke, Ursula Eilber, Stefan Nickels, Thilo Dörk, Maria Schiekel, Michael Bremer, Tjoung-Won Park-Simon, Graham G. Giles, Gianluca Severi, Laura Baglietto, Maartje J. Hooning, John W.M. Martens, Agnes Jager, Mieke Kriege, Annika Lindblom, Sara Margolin, Fergus J. Couch, Kristen N. Stevens, Janet E. Olson, Matthew Kosel, Simon S. Cross, Sabapathy P. Balasubramanian, Malcolm W.R. Reed, Alexander Miron, Esther M. John, Robert Winqvist, Katri Pylkäs, Arja Jukkola-Vuorinen, Saila Kauppila, Barbara Burwinkel, Frederik Marme, Andreas Schneeweiss, Christof Sohn, Georgia Chenevix-Trench, Diether Lambrechts, Anne-Sophie Dieudonne, Sigrid Hatse, Erik van Limbergen, Javier Benitez, Roger L. Milne, M. Pilar Zamora, José Ignacio Arias Pérez, Bernardo Bonanni, Bernard Peissel, Bernard Loris, Paolo Peterlongo, Preetha Rajaraman, Sara J. Schonfeld, Hoda Anton-Culver, Peter Devilee, Matthias W. Beckmann, Dennis J. Slamon et al. HUMAN MOLECULAR GENETICS
- Germline melanoma susceptibility and prognostic genes: A review of the literature
- (2012) Katherine A. Ward et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IRF5 gene polymorphisms in melanoma
- (2012) Lorenzo Uccellini et al. Journal of Translational Medicine
- Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study
- (2012) John R. Davies et al. Pigment Cell & Melanoma Research
- Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
- (2012) Romina Elizabeth Lenci et al. PLoS One
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma
- (2011) David Schrama et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis
- (2011) Sarah-Jane Schramm et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression
- (2011) Hongliang Liu et al. MELANOMA RESEARCH
- Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3
- (2011) Stuart MacGregor et al. NATURE GENETICS
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Susceptibility Loci Associated with Prostate Cancer Progression and Mortality
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- Biomarkers: The Useful and the Not So Useful—An Assessment of Molecular Prognostic Markers for Cutaneous Melanoma
- (2010) Bonnie E. Gould Rothberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
- (2010) S. Mocellin et al. JNCI-Journal of the National Cancer Institute
- Aberrant DNA methylation in malignant melanoma
- (2010) Carolina Schinke et al. MELANOMA RESEARCH
- Staging and Prognosis of Cutaneous Melanoma
- (2010) Paxton V. Dickson et al. Surgical Oncology Clinics of North America
- Cancer metastasis networks and the prediction of progression patterns
- (2009) L L Chen et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
- (2009) Marna G. Bouwhuis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA4) Common Polymorphisms on Outcome in Treatment of Melanoma Patients With CTLA-4 Blockade
- (2009) Willemijn B. Breunis et al. JOURNAL OF IMMUNOTHERAPY
- Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
- (2009) Bonnie E. Gould Rothberg et al. JNCI-Journal of the National Cancer Institute
- Betting on immunotherapy for melanoma
- (2009) Mario Sznol Current Oncology Reports
- MiTF Regulates Cellular Response to Reactive Oxygen Species through Transcriptional Regulation of APE-1/Ref-1
- (2008) Feng Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
- (2008) Erika M von Euw et al. Journal of Translational Medicine
- Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients
- (2008) Adina Figl et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More